---
description: The current system of clinical research is too slow, expensive, and imprecise.
---

# â˜  Problems We Seek To Address

#### &#x20;



{% content-ref url="../1-introduction-and-challenges/no-data-on-unpatentable-molecules.md" %}
[no-data-on-unpatentable-molecules.md](../1-introduction-and-challenges/no-data-on-unpatentable-molecules.md)
{% endcontent-ref %}

{% content-ref url="../1-introduction-and-challenges/lack-of-incentive-to-discover-the-full-range-of-applications-for-off-patent-treatments.md" %}
[lack-of-incentive-to-discover-the-full-range-of-applications-for-off-patent-treatments.md](../1-introduction-and-challenges/lack-of-incentive-to-discover-the-full-range-of-applications-for-off-patent-treatments.md)
{% endcontent-ref %}

{% content-ref url="../1-introduction-and-challenges/no-long-term-outcome-data.md" %}
[no-long-term-outcome-data.md](../1-introduction-and-challenges/no-long-term-outcome-data.md)
{% endcontent-ref %}

{% content-ref url="../1-introduction-and-challenges/conflicts-of-interest.md" %}
[conflicts-of-interest.md](../1-introduction-and-challenges/conflicts-of-interest.md)
{% endcontent-ref %}

{% content-ref url="../1-introduction-and-challenges/negative-results-are-never-published.md" %}
[negative-results-are-never-published.md](../1-introduction-and-challenges/negative-results-are-never-published.md)
{% endcontent-ref %}

{% content-ref url="../1-introduction-and-challenges/trials-often-arent-representative-of-real-patients.md" %}
[trials-often-arent-representative-of-real-patients.md](../1-introduction-and-challenges/trials-often-arent-representative-of-real-patients.md)
{% endcontent-ref %}

